Insider / Medline Inc.
BCP 8 Holdings Mozart Manager L.L.C.
Insider at Medline Inc.
- Company
- Medline Inc.
- Ticker
- MDLN
- First filing on record
- March 6, 2026
- Latest trade on record
- May 28, 2026
- SEC filings
- EDGAR ↗
BCP 8 Holdings Mozart Manager L.L.C., Insider at Medline Inc., has disclosed 28 transactions in MDLN since March 6, 2026: 0 purchases (0 open-market buys) and 8 sales, worth about $2.35B at the reported prices. The latest was filed June 1, 2026, 4 days after the trade; 6 filings were late against the 2-business-day Form 4 deadline.
Trading in charts
Trade timeline
When does this person trade, how big, and in which direction? Every trade in the last 12 months.
In the last 12 months BCP 8 Holdings Mozart Manager L.L.C. made no purchases and 8 sales worth $2.3B, plus 20 other transactions. Dot size is the dollar amount.
Portfolio mix
Which stocks does this person trade most? Tile size is dollars traded, all time on record.
BCP 8 Holdings Mozart Manager L.L.C. has traded 1 stock on record; the largest by dollars is MDLN.
Reporting lag
Does this person report on time? One bar per filing against the Form 4 deadline.
1 of 4 filings on record were reported after the Form 4 deadline (two business days, counted here as 4 calendar days).
What kind of transactions
Most Form 4 rows are pay arriving or tax being withheld, not a decision to buy or sell. Only code P is an open-market purchase and code S an open-market sale. What each code means: Form 4 transaction codes.
| Code | Meaning | Rows | Shares | Value |
|---|---|---|---|---|
| C | Conversion of a derivative | 12 | 41,671,930 | — |
| J | Other acquisition or disposal | 8 | 21,640,516 | — |
| S | Open-market sale | 8 | 61,170,810 | $2.35B |
| Year | Rows | Bought | Sold |
|---|---|---|---|
| 2026 | 28 | 0 | 8 · $2.35B |
Transactions
| Security | Side | Trade date | Disclosed | Lag | Shares | Price | Value | Flags | Source | Share |
|---|---|---|---|---|---|---|---|---|---|---|
| MDLN | Other J | May 28, 2026 | June 1, 2026 | 4d | 438,214 | — | — | indirect | Form 4 ↗ | |
| MDLN | Sell S | May 28, 2026 | June 1, 2026 | 4d | 1,489,924 | $37 | $54.4M | indirect | Form 4 ↗ | |
| MDLN | Sell S | May 28, 2026 | June 1, 2026 | 4d | 2,256,800 | $37 | $82.5M | indirect | Form 4 ↗ | |
| MDLN | Sell S | May 28, 2026 | June 1, 2026 | 4d | 9,858,774 | $37 | $360.2M | indirect | Form 4 ↗ | |
| MDLN | Sell S | May 28, 2026 | June 1, 2026 | 4d | 19,712,326 | $37 | $720.2M | indirect | Form 4 ↗ | |
| MDLN | Exchange C | May 21, 2026 | May 26, 2026 | 5d | 1,489,924 | — | — | lateindirectderivative | Form 4 ↗ | |
| MDLN | Exchange C | May 21, 2026 | May 26, 2026 | 5d | 9,858,774 | — | — | lateindirectderivative | Form 4 ↗ | |
| MDLN | Other J | May 21, 2026 | May 26, 2026 | 5d | 1,489,924 | — | — | lateindirect | Form 4 ↗ | |
| MDLN | Other J | May 21, 2026 | May 26, 2026 | 5d | 9,858,774 | — | — | lateindirect | Form 4 ↗ | |
| MDLN | Exchange C | May 21, 2026 | May 26, 2026 | 5d | 1,489,924 | — | — | lateindirect | Form 4 ↗ | |
| MDLN | Exchange C | May 21, 2026 | May 26, 2026 | 5d | 9,858,774 | — | — | lateindirect | Form 4 ↗ | |
| MDLN | Other J | March 10, 2026 | March 12, 2026 | 2d | 366,337 | — | — | indirect | Form 4 ↗ | |
| MDLN | Sell S | March 10, 2026 | March 12, 2026 | 2d | 1,245,544 | $41 | $50.5M | indirect | Form 4 ↗ | |
| MDLN | Sell S | March 10, 2026 | March 12, 2026 | 2d | 1,886,636 | $41 | $76.4M | indirect | Form 4 ↗ | |
| MDLN | Sell S | March 10, 2026 | March 12, 2026 | 2d | 8,241,723 | $41 | $333.9M | indirect | Form 4 ↗ | |
| MDLN | Sell S | March 10, 2026 | March 12, 2026 | 2d | 16,479,083 | $41 | $667.5M | indirect | Form 4 ↗ | |
| MDLN | Exchange C | March 5, 2026 | March 6, 2026 | 1d | 162,462 | — | — | indirectderivative | Form 4 ↗ | |
| MDLN | Exchange C | March 5, 2026 | March 6, 2026 | 1d | 1,075,007 | — | — | indirectderivative | Form 4 ↗ | |
| MDLN | Exchange C | March 4, 2026 | March 6, 2026 | 2d | 1,083,082 | — | — | indirectderivative | Form 4 ↗ | |
| MDLN | Exchange C | March 4, 2026 | March 6, 2026 | 2d | 7,166,716 | — | — | indirectderivative | Form 4 ↗ | |
| MDLN | Other J | March 5, 2026 | March 6, 2026 | 1d | 162,462 | — | — | indirect | Form 4 ↗ | |
| MDLN | Other J | March 5, 2026 | March 6, 2026 | 1d | 1,075,007 | — | — | indirect | Form 4 ↗ | |
| MDLN | Exchange C | March 5, 2026 | March 6, 2026 | 1d | 162,462 | — | — | indirect | Form 4 ↗ | |
| MDLN | Exchange C | March 5, 2026 | March 6, 2026 | 1d | 1,075,007 | — | — | indirect | Form 4 ↗ | |
| MDLN | Other J | March 4, 2026 | March 6, 2026 | 2d | 1,083,082 | — | — | indirect | Form 4 ↗ | |
| MDLN | Other J | March 4, 2026 | March 6, 2026 | 2d | 7,166,716 | — | — | indirect | Form 4 ↗ | |
| MDLN | Exchange C | March 4, 2026 | March 6, 2026 | 2d | 1,083,082 | — | — | indirect | Form 4 ↗ | |
| MDLN | Exchange C | March 4, 2026 | March 6, 2026 | 2d | 7,166,716 | — | — | indirect | Form 4 ↗ |
Filings
| Filed | Form | Accession | Rows | Status | Source |
|---|---|---|---|---|---|
| June 1, 2026 | Form 4 | 0001193125-26-251451 | 5 | published | EDGAR ↗ |
| May 26, 2026 | Form 4 | 0001193125-26-239438 | 6 | published | EDGAR ↗ |
| March 12, 2026 | Form 4 | 0001193125-26-104180 | 5 | published | EDGAR ↗ |
| March 6, 2026 | Form 4 | 0001193125-26-096827 | 12 | published | EDGAR ↗ |
Other insiders at Medline Inc.
- Hellman & Friedman Capital Partners X (Parallel), L.P. Insider 34 rows
- BX Mozart ML-1 Holdco L.P. Insider 18 rows
- Carlyle Group Inc. Insider 18 rows
- Carlyle Mozart Coinvestment Holdings, L.P. Insider 18 rows
- GIC Private Ltd Insider 16 rows
- Golwas Douglas P Chief Commercial Officer 14 rows
- Boyle James M Chief Executive Officer 13 rows
- Abrams William J See Remarks 10 rows
- BX Mozart ML-2 Holdco L.P. Insider 10 rows
- Liberman Alexander M. Chief Legal Officer 10 rows
Everyone on file, with contracts and lobbying under the company's name: Medline Inc..
Guides for this page
- What is SEC Form 4? Who files: officers, directors and owners of more than 10% of a class of the company's shares.
- Form 4 transaction codes P = purchase. S = sale. These are the two market trades.
- Insider buying vs insider selling Selling outweighs buying by a wide margin in normal times.
- Options and derivatives on Form 4 Table I = shares. Table II = options and other derivatives.
- What disclosure data cannot tell you Filings are late by design: up to 45 days for Congress, two business days for insiders.
Sources and method
| Source | Filings | Rows | First filed | Newest filed | Read the originals |
|---|---|---|---|---|---|
| SEC EDGAR, Form 4 | 4 | 28 | March 6, 2026 | June 1, 2026 | Form 4 list on EDGAR |
Site built October 22, 2026. Every row in the tables above links to its own filing. To quote a figure, use the Cite button at the top of the page; see how to cite and reuse.
Every row comes from the reporting owner's Form 4 as filed with the SEC (EDGAR ownership XML), read daily. "Value" is shares × the reported price; code P is an open-market purchase, S a sale, M an option exercise, A a grant. The lag is the filing date minus the trade date; Form 4 is due within two business days. Amendments (4/A) are not merged. Details on the methodology page; report an error on corrections.
Not investment advice. Figures are public disclosures shown as filed; they may lag the trade and may be amended later. No recommendation is made or implied.